{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:33:55Z","timestamp":1755794035781,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic graft-vs.-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation. It is a leading cause of long-term morbidity, non-relapse mortality, and impaired health-related quality of life. cGVHD is a multifactorial syndrome that can manifest with articular involvement. Approximately 50% of cGVHD survivors do not respond to glucocorticoid therapy used for arthritis. Subsequently, we shall present a case of a juvenile patient with arthritis and cGVHD, who responded well to intra-articular injection of tocilizumab, after bone marrow transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case pressentation<\/jats:title><jats:p>A male adolescent with acute myeloid leukemia successfully underwent marrow stem cell transplantation. However, he developed arthritis in the elbow and knee joints and had difficulty walking more than 3 months after transplantation. He was administered anti-rejection drugs with cyclosporine, ruxolitinib, and methylprednisolone by his physician, which did not work. He was subsequently treated with intravenous tocilizumab under the supervision of his rheumatologist. Although his clinical symptoms showed remission at early stages, his knee joints were more swollen, and he could not stand after being infected with COVID-19. Both of his knee joints was injected with tocilizumab at 0, 2, 4, 6, 7, 11, and 19 weeks. Interleukin (IL)-6 levels in the peripheral blood continuously decreased. After treatment for 4 months, the patient could walk a few hundred meters with minimal exertion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>An intra-articular injection of tocilizumab could be a viable treatment option for arthritis; however, large-scale clinical trials are warranted to confirm its efficacy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1515706","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:52:42Z","timestamp":1751435562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Intra-articular injection of tocilizumab for arthritis treatment in chronic graft-vs.-host disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingyu","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiting","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baimao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huasong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haisheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Graft-vs-Host disease working committee of the CIBMTR. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the center for international blood and marrow transplant research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41409-024-02370-8","article-title":"Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era","volume":"59","author":"Vadakkel","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jtct.2022.05.038","article-title":"Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 national institutes of health consensus project task force","volume":"28","author":"Cuvelier","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbmt.2019.10.019","article-title":"Disability related to chronic graft-versus-host disease","volume":"26","author":"Hamilton","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5045\/kjh.2011.46.2.80","article-title":"The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma","volume":"46","author":"Min","year":"2011","journal-title":"Korean J Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1038\/bmt.2008.294","article-title":"Innovative approaches to treat steroid-resistant or steroid refractory GVHD","volume":"42","author":"Berger","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1182\/blood.v98.5.1594","article-title":"Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation","volume":"98","author":"Cavet","year":"2001","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.0902-4441.2005.00568.x","article-title":"Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients","volume":"76","author":"Pihusch","year":"2006","journal-title":"Eur J Haematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","article-title":"Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation","volume":"17","author":"Tawara","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2217\/imt-2017-0173","article-title":"Tocilizumab in the treatment of adult rheumatoid arthritis","volume":"10","author":"Sanmart\u00ed","year":"2018","journal-title":"Immunotherapy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/1078155220948934","article-title":"Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease","volume":"27","author":"Melgarejo-Ortu\u00f1o","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00277-020-03968-w","article-title":"IL6-receptor Antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"99","author":"Kattner","year":"2020","journal-title":"Ann Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41409-018-0236-z","article-title":"Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract","volume":"54","author":"Ganetsky","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"822009","DOI":"10.3389\/fped.2022.822009","article-title":"Application of intra-articular corticosteroid injection in juvenile idiopathic arthritis","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10067-023-06530-x","article-title":"Efficacy of tumor necrosis factor inhibitor combined with intra-articular injection of triamcinolone acetonide in the treatment of refractory rheumatoid arthritis synovitis: a retrospective study","volume":"42","author":"Chen","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/1874471015666220128113319","article-title":"Interleukin 6 concentration in synovial fluid of patients with inflammatory and degenerative arthritis","volume":"18","author":"Mihailova","year":"2022","journal-title":"Curr Rheumatol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e107886","DOI":"10.1371\/journal.pone.0107886","article-title":"IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases","volume":"9","author":"Caiello","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1515706\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:52:44Z","timestamp":1751435564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1515706\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":21,"alternative-id":["10.3389\/fped.2025.1515706"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1515706","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1515706"}}